Literature DB >> 25287483

Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.

Susan L Uprichard1, Bruno Sainz2.   

Abstract

Keywords:  ANTIVIRAL THERAPY; HEPATITIS C

Mesh：

Substances：

Year:  2014        PMID： 25287483     DOI： 10.1136/gutjnl-2014-308396

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Depsides: lichen metabolites active against hepatitis C virus.

Authors:  Thi Huyen Vu; Anne-Cécile Le Lamer; Claudia Lalli; Joël Boustie; Michel Samson; Françoise Lohézic-Le Dévéhat; Jacques Le Seyec
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

2.  Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.

Authors:  Michael G Hughes; William W Tucker; Sreelatha Reddy; Michael E Brier; David Koch; Craig J McClain; Colleen B Jonsson; Nobuyuki Matoba; Donghoon Chung
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

Review 3.  New perspectives for preventing hepatitis C virus liver graft infection.

Authors:  Daniel J Felmlee; Audrey Coilly; Raymond T Chung; Didier Samuel; Thomas F Baumert
Journal:  Lancet Infect Dis       Date:  2016-06       Impact factor: 71.421
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.